ADDYI

This brand name is authorized in United States.

Active ingredients

The drug ADDYI contains one active pharmaceutical ingredient (API):

1	Flibanserin UNII 37JK4STR6Z - FLIBANSERIN
	Flibanserin is a multifunctional serotonin agonist and antagonist used for the treatment of premenopausal women with hypoactive sexual desire disorder. In vitro, flibanserin acts as an agonist on 5-HT1A receptors and an antagonist on 5-HT2A receptors. It also has moderate antagonist activities at the 5-HT2B, 5-HT2C, and dopamine D4 receptors.
	Read more about Flibanserin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ADDYI Film coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G02CX02		G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CX Other gynecologicals
Discover more medicines within G02CX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02473550
US	FDA, National Drug Code	58604-214